Vivaldi Capital Management »

Lenz Therapeutics shares owned by Vivaldi Capital Management

Quarter-by-quarter ownership of Lenz Therapeutics shares owned by Vivaldi Capital Management from 13F filings

Historical chart of Vivaldi Capital Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Vivaldi Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Vivaldi Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $924k 59k 15.73

More positions owned by Vivaldi Capital Management

Spdr Ser Tr Portfolio S&p500 (SPLG)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Apple (AAPL)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Gold Tr Ishares New (IAU)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Ishares Tr Core S&p Ttl Stk (ITOT)
Gaming & Leisure Pptys (GLPI)

View all positions for Vivaldi Capital Management

Top funds holding Lenz Therapeutics

RA Capital Management
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
Point72 Asset Management
Tang Capital Management
BlackRock
Vanguard Group
Alyeska Investment Group
Jennison Associates
Board of Trustees of The Leland Stanford Junior University
Geode Capital Management
Ikarian Capital
Prosight Management
BML Capital Management

View all funds holding Lenz Therapeutics